Abstract Methylglyoxal (MGO), an intermediate of advanced glycation end products (AGEs), is generated by the maillard reaction between carbonyl groups in reduced sugars and amino groups. The aim of this study was to examine inhibitory activities of kaempferol against the formation of AGEs by trapping MGO. Quantification and identification of MGO and Kaempferol MGO adduct was analyzed by ultra performance liquid chromatography with a photodiode array detector and mass spectrometry, respectively. 26.1, 29.5, 29.3, and 31.2% of MGO remained after reacting with 0.1, 0.25, 0.5, and 1.0 mM of kaempferol at 24 h of incubation time, respectively. The mono-or di-MGO adducts of kaempferol were identified, and hydroxyl groups in the A-ring of kaempferol were found to be the major active sites for trapping MGO. Results from the current study propose that kaempferol could suppress the formation of AGEs by trapping its reactive intermediate, MGO.
Introduction
Advanced glycation end products (AGEs) can be a cause in age-linked diseases such as cataracts, diabetic complications, hypertension, atherosclerosis, and Alzheimer's disease (Goldin et al. 2006; Yoon and Shim 2015) . The AGEs formation is initiated from the Maillard reaction, producing reversible Schiff bases in protein reactions with glucose, which is transformed into stable Amadori products by a rearrangement (Shangari et al. 2003; Wang 2010) . While this reaction occurs, methylglyoxal (MGO), an intermediate of AGEs, is generated by a reactive endogenous metabolite resulting from free radical generation of protein glycation and oxidation (Lv et al. 2011; Son and Shim 2015) . Since MGO is a highly reactive dicarbonyl compound, it makes intracellular AGEs formation faster. When the number of MGOs increases in the cells, it reacts considerably with proteins in order to form and accumulate irreversible AGEs (Verzijl et al. 2002; Bakris et al. 2004; Wang 2010; Yoon and Shim 2015) .
Inhibitors against MGO formation may possibly be beneficial compounds for AGE inhibition, resulting in antiaging and diabetes treatments. A number of synthetic compounds that serve as AGEs inhibitors such as aminoguanidine, carnosine, alagebrium, pyridoxamine, and metformin have been commercially available (Rahbar and Figarola 2003; Yoon and Shim 2015) . However, some side effects have been found. For instance, (Shao 2010) reported that the intake of aminoguanidine showed adverse health effects in the third stage of clinical trials with diabetes patients while it quenches AGEs formation.
Therefore, the development of an alternative product derived from natural ingredients is necessary. For instance, flavonoids including kaempferol, luteolin, naringenin, quercetin, rutin, and tea catechins have been investigated as inhibitors against AGEs formation under in vitro conditions (Shao 2010) . Wang (2010) reported that kaempferol from berry and grape extracts was identified to have the dicarbonyl trapping capability and inhibitory effects on AGE generation. However, results from those previous studies mainly focused on AGE inhibition rather than as an elucidated mechanism on the scavenging of reactive AGE precursors such as MGO.
Therefore, we hypothesized that MGO adduct would occur at the A-ring of kaempferol by trapping MGO. The purpose of this study was to investigate the AGEs inhibition effect of kaempferol by scavenging MGO and forming mono-and di-MGO adducts under physiological conditions.
Materials and methods

Standards and chemical reagents
Kaempferol and aminoguanidine bicarbonate were of analytical grade, purchased from Sigma-Aldrich (St. Louis, Mo, USA). Formic acid, methanol, and water for ultra performance liquid chromatography (UPLC) grade solutions were purchased from Fisher Scientific (Geel, Belgium), Sigma-Aldrich, and J.T. Baker (Phillipsburg, NJ, USA), respectively. Methylglyoxal (40% in water) and ophenylenediamine were obtained from Sigma-Aldrich.
Kinetics assay of methylglyoxal (MGO) trapping
The MGO trapping assay was performed consistent with the methods of Yoon and Shim (2015) . MGO and o-phenylenediamine were made with a phosphate buffer solution (PBS, 100 mM, pH 7.4). Kaempferol and aminoguanidine were prepared for each concentration (0.1, 0.25, 0.5, 1.0 mM) and used as standard material and positive control, respectively. Kaempferol was mixed with 1 mM of MGO in the PBS. The mixtures were incubated at 37°C with a speed of 40 rpm and then gathered at 0, 30, 60, 120, 240, 480 , and 1440 min. Then, acetic acid (1 lL) was added to finish the reaction and the derivatization of the remaining MGO in an aliquot amount of each sample (200 lL) was carried out by adding ophenylenediamine (100 mM).
Identification and quantification of remaining MGO by UPLC-PDA/ESI/MS/MSn analysis
UPLC was furnished with an Accela photodiode array (PDA) detector, an Accela autosampler, an Accela 600 pump, and an LCQ fleet (Thermo Scientific, Vantaa, Finland), which was utilized to quantify MGO. Electrospray ionization-Mass spectrometry (ESI-MS) was conducted for identification of the MGO kaempferol adducts. Hypersil GOLD column (50 9 2.1 mm, 1.9 lm, Thermo Scientific, Vantaa, Finland) was used at room temperature. The flow rate was fixed at 0.2 mL/min and the injection volume was 1 lL. The binary mobile phases were composed of A (0.2% formic acid in 90% water and 10% methanol) and B (0.2% formic acid in 100% methanol). The linear gradient for column elution was carried out according to a previous study (Yoon and Shim 2015) . The wavelength for a sample and MGO detection was set at 315 nm. After separation by LC, MS scanning was carried out with both positive and negative polarity modes. The sheath gas flow rate and auxiliary gas were 27.0 and 14.0 arb, respectively. Additional operating conditions of the mass spectrometer were along these lines: capillary voltage 2.00 V and capillary temperature 260.00°C
; mass spectrums of chromatographic peaks were displayed by identified samples, which were able to confirm retention times and molecular weights, respectively.
Results and discussion
When it comes to mechanisms on scavenging MGO, previous studies have found that A-ring of flavonoids (Fig. 1A) was the major active site for trapping MGO (Shao 2010; Lv et al. 2011) . Vicinal dihydroxyl groups of flavonoid could be the active sites to trap MGO and form MGO adducts (Sang et al. 2007; Lv et al. 2011 ). For instance, it was revealed that EGCG and quercetin containing vicinal hydroxyl groups inhibited the formation of MGO during protein glycation (Cervantes-Laurean et al. 2006; Pashikanti et al. 2010) . Kaempferol is a phenolic compound, a kind of flavonoids, composed of typical C6-C3-C6 structure (Fig. 1B) . Two hydroxyl groups (-OH) are attached to A-ring and both Band C-ring additionally have one isolated -OH group (Brett and Ghica 2003) . A variety of fruits including apples, onions, citrus, grapes, and red pepper herbs that contain kaempferol are known to provide anti-inflammatory, antimicrobial, anticancerous, and antioxidant properties (Brett and Ghica 2003; Pan et al. 2010; Shao 2010) . Figure 2 shows that three peaks were detected at 0.79, 4.91, and 5.70 min of retention time using the UPLC-PDA detector at 320 nm ( Fig. 2A) . The molecular weight of each peak at each retention time was confirmed by its mass spectrum of chromatogram (Fig. 2B) . In this study, the positive ion mode indicated superior results in the ESI-MS analysis. The first peak detected at the retention time of 0.79 min corresponded to the molecular weight of o- ? at m/z 108.99 (Fig. 2B) . Its structure is shown in Fig. 2C . Peak 2 eluted at a retention time of 4.91 min and was identified as derivatives of MGO, 1-methylquinoxaline by ESI-MS with [M ? H] ? ion at m/z 145.03 ( Fig. 2A, B) . For peak 3, [M ? H] ? was observed at m/z 285.10 at the retention time of 5.70, which is identified as kaempferol. Chemical structures of both 1-methylquinoxaline and kaempferol are exhibited in Fig. 2C .
The amount of MGO after reacting with various concentrations of aminoguanidine or kaempferol during 1440 min of incubation at 37°C was measured (Fig. 3) . MGO itself as a negative control was stable during the reaction, showing a range from 91 to 100%. MGO was scavenged up to 60% by 0.25 mM of aminoguanidine, a positive control, but its inhibitory effect was not dose dependent. In contrast to the positive control, the remaining MGO after reacting with kaempferol significantly decreased up to 32% in a dose-dependent manner, particularly in the early incubation time (0-30 min). Overall, kaempferol was more effective on scavenging MGO than the positive control at each concentration, showing as 1.38-1.83 times higher. The results from the current study suggest that kaempferol could inhibit early stages of AGE formation by scavenging MGO under physiological conditions. Compared to commercial drugs, certain flavonoids have been known to be more effective inhibitors against AGE generation (Lo et al. 2006; Urios et al. 2007 ). Wang (2010) found that chlorogenic acid and quercetin more significantly scavenged MGO for 9.2 and 5.5 h incubation, respectively, compared with aminoguanidine. A previous study also reported that luteolin, quercetin, and rutin were more effective in MGO inhibition, showing 53.6, 55.4, and 66.1%, respectively than that of aminoguanidine (25%) (Wu and Yen 2005) . In a kinetic study, the concentration of MGO was dramatically reduced with a range of 1:1 molar ratios of epicatechins in green tea and theaflavins in black tea to MGO (Lo et al. 2006) .
Studies revealed that MGO scavenging capacity depends on the location and the number of the hydroxyl group (-OH) of the polyphenol structure (Shao 2010) . For instance, many dietary flavonoids including quercetin, EGCG, and rutin provided significant scavenging capacity by acting as an MGO inhibitor under physiological conditions (Huang et al. 2010; Wang 2010; Lo et al. 2011) . These flavonoids have their identical A-, C-, and B-ring structure added to several hydroxyl groups, particularly. MGO scavenging capacity depends on the amount of -OH moieties at the A-ring (Sang et al. 2007; Shao 2010; Wang 2010) . Quercetin and luteolin having -OH moieties at the A-ring was demonstrated to have more than 90% of MGO trapping capacity within 24 h physiological conditions (Shao 2010 ). Thus, it is possible that significant scavenging capacity of MGO by kaempferol resulted from mono-or di-MGO adducts with OH at the A-ring of kaempferol.
In order to elucidate the mechanism on trapping MGO by kaempferol, we further identified both mono-and di-MGO adducts of kaempferol using LC/MS/MSn. As shown in Fig. 4A , unknown peaks at the retention time of (2017) 60(1) were the molecular weights added to 72 and 144 mass units to the molecular weight of kaempferol, respectively. Based on these results, the current study proposed structures of both mono-MGO adducts and di-MGO adducts of kaempferol (Fig. 4C) . Several previous studies reported that MGO adducts were formed by trapping MGO at the active site of the A-ring of flavonoids such as quercetin, myricetin, and phloretin that have similar backbone structures as kaempferol (Sang et al. 2007; Shao 2010; Wang 2010) . For instance, some of the major bioactive polyphenols in apples (such as phloretin and its glucoside, phloridzin) could be effective in trapping the highly reactive MGO by forming mono-and di-MGO adducts (Shao 2010) . It was reported that reactive dicarbonyl intermediates such as MGO could be nucleophilic chelate, trapper, and conjugator (Cervantes-Laurean et al. 2006; Pashikanti et al. 2010) . The nucleophilic condition is made by slightly alkaline pH, which promotes the formation of mono-and di-MGO adducts at the 6 and 8 sites of the A-ring of EGCG, respectively (Shao 2010) . Similar to EGCG, quercetin, and myricetin, kaempferol composed of the same A-ring structure may scavenge MGO by forming MGO adduct at the active site of the A-ring. Thus, results from our study suggest that early AGE generation could be suppressed by the formation of MGO adducts and the conjugation of kaempferol at the active site of the A-ring.
The remaining MGO (%) after reacting with kaempferol decreased by approximately 1-32% with concentration dependent during incubation time (1440 min). Unknown peaks eluted in the PDA detector at 4 h incubation time was proposed to mono-and di-MGO adducts with kaempferol. Results from the current study found that kaempferol plays an effective role as a potent AGE inhibitor by scavenging MGO and forming mono-MGO adducts and di-MGO adducts. On the basis of our results, kaempferol could effectively be a beneficial compound for MGO inhibitor, during early AGEs formation. Therefore, inhibitory effects of kaempferol on AGE formation by long-term physiological conditions should be further examined.
